Literature DB >> 11564367

Prognostic factors in juvenile idiopathic arthritis.

A M Prieur1, G Chèdeville.   

Abstract

Prognostic factors in juvenile arthritis are related to many variables that must be evaluated according to the different subtypes. The International League of Associations of Rheumatologists (ILAR) recently proposed six different categories referred to as the Durban criteria, under the eponym of juvenile idiopathic arthritis (JIA). The aim of this classification was to define homogeneous groups according to their clinical and biologic features. The prognostic factors were classified into the different categories of JIA. A poor outcome in the systemic form correlated with markers of disease activity, such as fever and polyarticular involvement, within the first 6 months. The risk of joint destruction in oligoarthritis correlated with the severity of arthritis within the first 2 years. Polyarthritis with positive rheumatoid factor is associated with marked disability in adulthood. In a group of psoriatic patients, the risk of developing sacroiliitis is higher in male and HLA-B27-positive patients. Patients with enthesitis-related arthritis with lower limb, knee, and tarsal involvement also are at greater risk of developing sacroiliitis. Chronic uveitis is a complication of JIA observed mainly in patients with oligoarthritis associated with positive antinuclear antibodies in serum. Secondary amyloidosis is observed mainly in children with systemic JIA. The long-term outcome must be discussed according to the various therapies. Corticosteroids contribute to growth retardation and osteoporosis, for which the use of human recombinant growth hormone and biphosphonates may be an option. Newer encouraging therapies such as anticytokines have been proposed for children with active disease. Autologous stem cell transplantation is being evaluated in some centers with promising results; however, it has a high rate of mortality. Further discussion regarding which patients should undergo autologous stem cell transplantation is needed, as is further discussion regarding the technical adaptations necessary.

Entities:  

Mesh:

Year:  2001        PMID: 11564367     DOI: 10.1007/s11926-996-0006-6

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.686


  58 in total

1.  Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997.

Authors:  R E Petty; T R Southwood; J Baum; E Bhettay; D N Glass; P Manners; J Maldonado-Cocco; M Suarez-Almazor; J Orozco-Alcala; A M Prieur
Journal:  J Rheumatol       Date:  1998-10       Impact factor: 4.666

2.  Comparison of long term evolution of adult onset and juvenile onset Still's disease, both followed up for more than 10 years.

Authors:  J Cabane; A Michon; J M Ziza; P Bourgeois; O Blétry; P Godeau; M F Kahn
Journal:  Ann Rheum Dis       Date:  1990-05       Impact factor: 19.103

3.  Follow-up study of juvenile chronic polyarthritis with particular reference to histocompatibility antigen W. 27.

Authors:  J Edmonds; R I Morris; A L Metzger; R Bluestone; P I Terasaki; B Ansell; E G Bywaters
Journal:  Ann Rheum Dis       Date:  1974-07       Impact factor: 19.103

4.  Juvenile rheumatoid arthritis and lymphoedema: lymphangiographic aspects.

Authors:  P Schmit; A M Prieur; F Brunelle
Journal:  Pediatr Radiol       Date:  1999-05

5.  Pregnancy and early onset pauciarticular juvenile chronic arthritis.

Authors:  E Musiej-Nowakowska; R Ploski
Journal:  Ann Rheum Dis       Date:  1999-08       Impact factor: 19.103

6.  Efficacy of recombinant human growth hormone in children with juvenile rheumatoid arthritis and growth failure.

Authors:  A Al-Mutair; S Bahabri; S Al-Mayouf; A Al-Ashwal
Journal:  J Pediatr Endocrinol Metab       Date:  2000 Jul-Aug       Impact factor: 1.634

7.  Development of diabetes mellitus during etanercept therapy in a child with systemic-onset juvenile rheumatoid arthritis.

Authors:  B J Bloom
Journal:  Arthritis Rheum       Date:  2000-11

8.  The extended oligoarticular subtype is the best predictor of methotrexate efficacy in juvenile idiopathic arthritis.

Authors:  A Ravelli; S Viola; D Migliavacca; N Ruperto; A Pistorio; A Martini
Journal:  J Pediatr       Date:  1999-09       Impact factor: 4.406

9.  HLA B27: a prognostic factor in juvenile chronic arthritis.

Authors:  H A Savolainen; M Lehtimäki; H Kautiainen; K Aho; P Anttila
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

10.  Axial involvement in the seronegative enthesopathy and arthropathy syndrome and its progression to ankylosing spondylitis.

Authors:  R Burgos-Vargas; P Clark
Journal:  J Rheumatol       Date:  1989-02       Impact factor: 4.666

View more
  8 in total

Review 1.  Autologous haematopoietic stem cell transplantation in juvenile idiopathic arthritis.

Authors:  L R Wedderburn; M Abinun; P Palmer; H E Foster
Journal:  Arch Dis Child       Date:  2003-03       Impact factor: 3.791

Review 2.  Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.

Authors:  Christine R Culy; Gillian M Keating
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Management of juvenile idiopathic arthritis.

Authors:  Sujata Sawhney
Journal:  Indian J Pediatr       Date:  2002-10       Impact factor: 1.967

4.  How should a district general hospital immunology service screen for anti-nuclear antibodies? An 'in-the-field' audit.

Authors:  R Hira-Kazal; P Shea-Simonds; J L Peacock; J Maher
Journal:  Clin Exp Immunol       Date:  2015-04       Impact factor: 4.330

Review 5.  Implications of SARS-CoV-2 Infection in Systemic Juvenile Idiopathic Arthritis.

Authors:  Laura Marinela Ailioaie; Constantin Ailioaie; Gerhard Litscher
Journal:  Int J Mol Sci       Date:  2022-04-12       Impact factor: 6.208

6.  Do patients with juvenile idiopathic arthritis in clinical remission have evidence of persistent inflammation on 3T magnetic resonance imaging?

Authors:  Amanda Brown; Raphael Hirsch; Tal Laor; Michael J Hannon; Marc C Levesque; Terence Starz; Kimberly Francis; C Kent Kwoh
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-12       Impact factor: 4.794

7.  Profiling risk factors for chronic uveitis in juvenile idiopathic arthritis: a new model for EHR-based research.

Authors:  Tyler S Cole; Jennifer Frankovich; Srinivasan Iyer; Paea Lependu; Anna Bauer-Mehren; Nigam H Shah
Journal:  Pediatr Rheumatol Online J       Date:  2013-12-03       Impact factor: 3.054

Review 8.  Molecular and Cellular Mechanisms of Arthritis in Children and Adults: New Perspectives on Applied Photobiomodulation.

Authors:  Laura Marinela Ailioaie; Gerhard Litscher
Journal:  Int J Mol Sci       Date:  2020-09-08       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.